Company / SG&A Expense
SRx Health Solutions, Inc. SG&A Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$12.9M
FY2025
5-year range
$12.9M / $35.4M
FY2021-FY2025
Trend
-47.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A Expense has fluctuated over the past 10 years, ranging from $7,168 in FY2016 to $35M in FY2023.
Based on SEC 10-K filings.
$13M in FY2025 with a 5-year CAGR of -8.2%.
Improved from $35M to $13M over the past 2 years.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- -23.2%
- 5-Year CAGR
- -8.2%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -8.2%, indicating a declining trend.
- In FY2025, sg&a expense decreased 47.1% year-over-year.
- Peak sg&a expense was recorded in FY2023.
- Lowest sg&a expense in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $12.9M | -47.1% |
| FY2024 | $24.4M | -31.0% |
| FY2023 | $35.4M | +24.3% |
| FY2022 | $28.5M | -17.3% |
| FY2021 | $34.5M | +74.3% |
| FY2020 | $19.8M | +226.7% |
| FY2019 | $6.1M | +1052.4% |
| FY2018 | $525.4K | +297.3% |
| FY2017 | $132.2K | +1745.0% |
| FY2016 | $7.2K | -3.6% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026